The purpose of this study was to assess mid-term survivorship following primary total knee arthroplasty (TKA) with Optetrak Logic components and identify the most common revision indications at a single institution. We identified a retrospective cohort of 7,941 Optetrak primary TKAs performed from January 2010 to December 2018. We reviewed the intraoperative findings of 369 TKAs that required revision TKA from January 2010 to December 2021 and the details of the revision implants used. Kaplan-Meier analysis was used to determine survivorship. Cox regression analysis was used to examine the impact of patient variables and year of implantation on survival time.Aims
Methods
Instability following total knee arthroplasty is a leading cause of failure and is often treated with component revision. The goal of this study was to determine if isolated tibial polyethylene insert exchange (ITPIE) to a higher-level constraint would afford similar outcomes to component revision in the properly selected patient. We retrospectively evaluated 176 consecutive patients between 2016–2017 who were revised for symptomatic instability at a single institution. Demographic information and level of constraint preoperatively and postoperatively were documented. Radiographic parameters were also recorded for patients undergoing ITPIE. Outcome measures included all cause re-revision rates as well as patient reported outcome measures (PROMs) obtained preoperatively and at minimum 1-yr follow up. Descriptive analysis including sample t-test and chi square test were performed with statistical significance set at p <0.05.Introduction
Methods
The purpose of this investigation was to determine the relationship between height, weight, and sex with implant size in total knee arthroplasty (TKA) using a multivariate linear regression model and a Bayesian model. A retrospective review of an institutional registry was performed of primary TKAs performed between January 2005 and December 2016. Patient demographics including patient age, sex, height, weight, and body mass index (BMI) were obtained from registry and medical record review. In total, 8,100 primary TKAs were included. The mean age was 67.3 years (SD 9.5) with a mean BMI of 30.4 kg/m2 (SD 6.3). The TKAs were randomly split into a training cohort (n = 4,022) and a testing cohort (n = 4,078). A multivariate linear regression model was created on the training cohort and then applied to the testing cohort . A Bayesian model was created based on the frequencies of implant sizes in the training cohort. The model was then applied to the testing cohort to determine the accuracy of the model at 1%, 5%, and 10% tolerance of inaccuracy.Aims
Methods
Obesity has been shown to be an independent risk factor for aseptic loosening of the tibia and smaller implant size has been correlated with increased risk of failure of tibial components in obese patients [1,2]. Many surgeons have noted that obese patients, especially females, not uncommonly will have small implant sizes. As such, we hypothesized that obesity was not directly correlated with total knee arthroplasty (TKA) implant sizes. The purpose of this study was to determine if increasing body mass index (BMI), height, and/or weight is associated with implant size in primary TKA. The institutional registry of a single academic center was reviewed to identify all primary TKAs performed between 2005 and 2016. Those without minimum 2-year follow-up or with incomplete implant data were excluded. The different manufacturer's implant designs were categorized based on anteroposterior and mediolateral dimensions of the femoral and tibial component sizes and cross sectional area was determined. BMI was categorized by the World Health Organization (WHO) obesity scale (Class I: BMI 30 to <35, Class II: BMI 35 to <40, Class III: BMI 40 kg/m2 or greater). Patient demographics including sex, height, weight, and BMI were analyzed to evaluate correlations with implant size using Pearson correlation coefficients.Background
Methods
Primary total knee arthroplasties (TKA) performed in younger patients raise concerns regarding the potential for accelerated polyethylene wear, aseptic loosening, and thus revision TKA at a younger age. The purpose of this study was to determine the long-term implant survivorship, functional outcomes, and pain relief of primary TKA performed in patients under 35 years of age. A retrospective review of our institutional registry identified 185 TKAs performed in 119 patients under the age of 35 between 1985 and 2010. Medical records and radiographs were reviewed. Patients were contacted for two serial questionnaires in 2011–2012 and again in 2018. Implant survivorship was calculated using Kaplan-Meier survivorship curves and Cox proportional hazard model. The median age was 26.1 (21.5–30.1) years, with a BMI of 23.5 (20.4–26.6) kg/m2. Median follow-up was 13.9 (8.5–19.8) years.Introduction
Methods
The outcomes of total knee arthroplasty (TKA) depend on many factors. The impact of implant design on patient-reported outcomes is unknown. Our goal was to evaluate the patient-reported outcomes and satisfaction after primary TKA in patients with osteoarthritis undergoing primary TKA using five different brands of posterior-stabilized implant. Using our institutional registry, we identified 4135 patients who underwent TKA using one of the five most common brands of implant. These included Biomet Vanguard (Zimmer Biomet, Warsaw, Indiana) in 211 patients, DePuy/Johnson & Johnson Sigma (DePuy Synthes, Raynham, Massachusetts) in 222, Exactech Optetrak Logic (Exactech, Gainesville, Florida) in 1508, Smith & Nephew Genesis II (Smith & Nephew, London, United Kingdom) in 1415, and Zimmer NexGen (Zimmer Biomet) in 779 patients. Patients were evaluated preoperatively using the Knee Injury and Osteoarthritis Outcome Score (KOOS), Lower Extremity Activity Scale (LEAS), and 12-Item Short-Form Health Survey questionnaire (SF-12). Demographics including age, body mass index, Charlson Comorbidity Index, American Society of Anethesiologists status, sex, and smoking status were collected. Postoperatively, two-year KOOS, LEAS, SF-12, and satisfaction scores were compared between groups.Aims
Patients and Methods
